Rivus Pharmaceuticals Presents Preclinical Data for Controlled Metabolic Accelerator (CMA) Pipeline Showing Fat-Selective, Muscle-Preserving Weight Loss in Obesity at …

First data from Rivus’ preclinical CMA pipeline showing potential as monotherapy and in combination with ...